Cargando…
含新药诱导化疗序贯自体造血干细胞移植、维持治疗策略治疗多发性骨髓瘤300例——单中心回顾性研究
OBJECTIVE: To examine the survival and influential factors of an integrated approach of novel agents, autologous hematopoietic stem cell(auto-HSCT), and maintenance therapy in patients with multiple myeloma(MM)patients from a single center over the past 15 years. METHODS: In our center, 300 MM patie...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939329/ https://www.ncbi.nlm.nih.gov/pubmed/36709105 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.12.005 |
Ejemplares similares
-
含硼替佐米方案诱导序贯自体造血干细胞移植治疗多发性骨髓瘤——单中心200例长期随访结果
Publicado: (2019) -
新免疫治疗时代下复发难治性霍奇金淋巴瘤治疗新策略
Publicado: (2019) -
诱导治疗序贯自体外周血造血干细胞移植后201例多发性骨髓瘤患者的疗效及预后影响因素
Publicado: (2016) -
炎症性贫血治疗新趋势
Publicado: (2018) -
替代供者移植治疗儿童获得性再生障碍性贫血109例:单中心回顾性分析
Publicado: (2020)